During the past decade, Mount Sinai School of Medicine IBD Research Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mount Sinai School of Medicine IBD Research Center" #1 sponsor was "Icahn School of Medicine at Mount Sinai" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Abbott" with 1 trials sponsored, "Jacobus Pharmaceutical" with 1 trials sponsored and "Ocera Therapeutics" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mount Sinai School of Medicine IBD Research Center" #1 collaborator was "Janssen Scientific Affairs, LLC" with 1 trials as a collaborator and "Prometheus Laboratories" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Mount Sinai School of Medicine IBD Research Center" are "Crohn's Disease" (3 trials), "Inflammatory Bowel Disease" (2 trials), "Ulcerative Colitis" (2 trials) and "Intestinal Fistula" (1 trials). Many other conditions were trialed in "Mount Sinai School of Medicine IBD Research Center" in a lesser frequency.

Most popular intervention types in "Mount Sinai School of Medicine IBD Research Center" are "Drug" (5 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CP-690,550" (2 trials), "4-Aminosalicylic acid" (1 trials), "AST-120" (1 trials), "Adalimumab" (1 trials) and "CP690,550" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mount Sinai School of Medicine IBD Research Center" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Mount Sinai School of Medicine IBD Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Mount Sinai School of Medicine IBD Research Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mount Sinai School of Medicine IBD Research Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".